The Trip Report cover image

#24 Manesh Girn Ph.D. - Exploring the Psychedelic Brain and Human Potential

The Trip Report

NOTE

Realities and Optimism in the Psychedelics Industry

The psychedelics industry is experiencing a dichotomy with some individuals still enthusiastic about its potential for revolutionizing mental health treatment while others are becoming more cautious due to past setbacks and challenges. There is a realization that the journey is not as easy or lucrative as initially thought, with concerns around the efficacy and reach of treatments. Funding is scarce, and many companies are struggling in the current climate. Despite these challenges, there is optimism about the industry's growth, with predictions of psilocybin approval for depression by 2028 through Compass Pathways. The upcoming MDMA approval could also be a significant turning point. Overall, there is a sense of anticipation and readiness for the industry to take off in the coming years.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner